Two ‘not cost effective’ drugs face being dropped from cancer drugs fund
Two drugs may be dropped from the cancer drugs fund (CDF) after the National Institute for Health and Care Excellence (NICE) deemed them “not cost effective”.
In draft guidance published on 18 August 2016, appraisals carried out by NICE under the new CDF system conclude that …